Targeted Therapy Finder

« All News Items

CollabRx Teams with MedPage Today to Introduce Digital Tool for Patient-Specific Genomic Approaches to Cancer Treatment

Posted in CollabRx News, Targeted Therapy Finder by Ben Kaplan on August 8, 2012 | No Comments »

August 8, 2012 – 

CollabRx has begun to provide a version of its proprietary Therapy Finder tool to MedPage Today, Everyday Health’s rapidly growing online site that serves 96% of all oncologists and 1.6 million monthly online unique users.

CollabRx apps discussed in the British Journal of Healthcare Computing

Posted in CollabRx News, Publications, Targeted Therapy Finder, Targeting Cancer by Ben Kaplan on June 21, 2012 | No Comments »

June 20, 2012 – 

The CollabRx Colorectal Targeted Therapy App, and our relationship with CAP (The College of American Pathologists) is briefly described in the latest issue of the British Journal of Healthcare Computing. The article quotes the chief editor of the app, Dr Heinz-Josef Lenz, professor at the Keck School of Medicine, University of Southern California: “The Therapy Finder – Colorectal Cancer app is a novel and much needed educational resource that provides cancer patients and physicians access to complex and highly valuable information about how tumour genetics can be used to guide through clinical trials and treatment options. This is one of the first sites which uses a cutting-edge approach for biomarker driven chemotherapy.”

Cancer Commons Researchers Publish Molecular Disease Model for Lung Cancer

Posted in CollabRx News, Publications, Targeted Therapy Finder, Targeting Cancer by Ben Kaplan on February 28, 2012 | No Comments »

PALO ALTO, Calif.–(BUSINESS WIRE)–Cancer Commons, an open‐science initiative to personalize cancer treatments and accelerate research, announces the publication of a molecular disease model (MDM) for lung cancer. The paper, by Lisandra West, Ravi Salgia, and others will appear in the February 21st issue of PLoS ONE. continue reading »

CollabRx partners with The College of American Pathologists Partners to Provide Personalized Decision Tools to Cancer Patients

Posted in CollabRx News, Events, Targeted Therapy Finder by Ben Kaplan on February 28, 2012 | No Comments »

March 13, 2012 – 

Northfield, IL—The College of American Pathologists (CAP) announced today its partnership with CollabRx to provide patients with advanced stage lung or skin cancer access to the cutting-edge information on cancer therapies that could change their lives. Patients can now download the CollabRx Targeted Therapy Finder apps through the College’s website, and their patient portal, MyBiopsy.org, to find the latest information on diagnostic tests, clinical trials, and approved and emerging cancer therapies.

Lung Cancer Molecular Disease Model Published in PLoS ONE

Posted in CollabRx News, Publications, Targeted Therapy Finder, Targeting Cancer by Jeff Shrager on February 22, 2012 | No Comments »

A team including leading lung cancer researchers, and CollabRx scientists, has just published a novel Lung Cancer Molecular Disease Model in PLoS ONE, a leading peer-reviewed open source journal. (click here to read the published paper online). This is the model that underlies the CollabRx Lung Cancer Targeted Therapy Finder App.